NVS  Novartis Ag

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

210.0B

Vuru Grade

66.99/100

Current Price

$86.56
+1.10 (+1.29%)

Growth Price

$78.89
Overvalued by 8.86%

Stability Price

$26.59
Overvalued by 69.28%

Company Metrics

  • 23.1 P/E
  • 3.52 P/S
  • 2.79 P/B
  • 3.7 EPS
  • 16.94% Cash ROIC
  • 0.21 Cash Ratio
  • 2.719 / 3.18% Dividend
  • 1.90M Avg. Vol.
  • 2.43B Shares
  • 210.0B Market Cap.

Company Description

Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide. Its Pharmaceuticals division offers prescription medicines in various therapeutic areas, including cardiovascular and metabolism; oncology; neuroscience and ophthalmics; respiratory; integrated hospital care; and other additional products. The company's Vaccines...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.